AMG 102 at 20 mg/kg

DRUG2 trials

Sponsors

Amgen

Conditions

Advanced Malignant GliomaAdvanced Renal Cell Carcinoma

Phase 2

A Phase II Study to Treat Subjects With Advanced Renal Cell Carcinoma

CompletedNCT00422019

AmgenAdvanced Renal Cell Carcinoma

Start: 2007-01-31End: 2009-03-31Updated: 2015-04-10

A Phase II Study to Treat Advanced Malignant Glioma

CompletedNCT00427440

AmgenAdvanced Malignant Glioma

Start: 2006-11-30End: 2013-04-30Updated: 2015-04-27

Related Papers

DI-033 Clinical response of rilotumumab in solid tumours

2016-02-14